Results 151 to 160 of about 56,967 (294)

Pain Experiences and Prescription Pain Medications Among People With Selected Muscular Dystrophies in the Muscular Dystrophy Surveillance, Tracking, and Research Network

open access: yesMuscle &Nerve, Volume 72, Issue 3, Page 475-484, September 2025.
ABSTRACT Introduction/Aims Pain is a recognized symptom of muscular dystrophy (MD), but little is known about prescription pain medications in this population. We describe pain experiences and pain medications prescribed for individuals with selected MDs using population‐based surveillance data collected by the Muscular Dystrophy Surveillance, Tracking,
Jonathan Suhl   +9 more
wiley   +1 more source

Amitriptyline potently neutralizes distinct SARS-CoV-2 variants including D614G, Omicron BA.5, and Omicron XBB.1. [PDF]

open access: yesFront Microbiol
Zydek I   +13 more
europepmc   +1 more source

Amitriptyline for neuropathic pain in adults.

open access: yesCochrane Database of Systematic Reviews, 2015
R. A. Moore   +4 more
semanticscholar   +1 more source

The rise and fall of “Nippon no utsu‐byo ニッポンのうつ病” (the concept of Nippon depressive disease) in Japan

open access: yesPsychiatry and Clinical Neurosciences Reports, Volume 4, Issue 3, September 2025.
Abstract From around 1960 to 2000, Japanese psychiatrists used their own concept of depression (Utsu‐byo うつ病). To distinguish this from major depressive disorder (MDD), the present concept of depression according to the revised version of the Diagnostic and Statistical Manual of Mental Disorders, 5th edition, the present author refers to this concept ...
Susumu Ohmae
wiley   +1 more source

Effects of Desipramine, Amitriptyline, and Fluoxetine on Pain in Diabetic Neuropathy [PDF]

open access: bronze, 1992
Mitchell B. Max   +5 more
openalex   +1 more source

Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study.

open access: yesGastroenterology, 2015
N. Talley   +19 more
semanticscholar   +1 more source

Embedding Pharmacogenetics Into Clinical Practice to Improve Patient Outcomes

open access: yesAnnals of Human Genetics, Volume 89, Issue 5, Page 398-405, September 2025.
ABSTRACT Pharmacogenomics, the use of germline genomic data to guide prescription to improve effective and safer medication, holds promise as a clinical intervention. To date in most health systems, there has been limited uptake of pharmacogenomic testing confined to a few single drug–gene associations.
John Henry McDermott   +3 more
wiley   +1 more source

Real‐World Multinational Survey of Chronic Inflammatory Demyelinating Polyneuropathy: Disease Characteristics and Therapeutic Landscape

open access: yesJournal of the Peripheral Nervous System, Volume 30, Issue 3, September 2025.
ABSTRACT Background and Aims Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune‐mediated syndrome characterized by progressive muscle weakness and sensory impairment. Clinical similarities with other neuropathies can cause misdiagnoses and delayed diagnoses. Additionally, a large proportion of patients appropriately treated according
Luis Querol   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy